Trokendi XR FDA Approval History
FDA Approved: Yes (First approved August 16, 2013)
Brand name: Trokendi XR
Generic name: topiramate
Company: Supernus Pharmaceuticals, Inc.
Treatment for: Epilepsy
Trokendi XR (topiramate) is an antiepileptic drug indicated for the treatment of epilepsy.
Development Timeline for Trokendi XR
|Aug 19, 2013||ApprovalSupernus Announces Final FDA Approval and Upcoming Launch of Trokendi XR|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.